Casgevy is now approved in the U.S. for children with sickle cell as young as 2, becoming the first gene-editing therapy for ...

VAS-101, a curcumin-based gel for SCD, was well tolerated and showed signs of easing sickle cell pain, fatigue, and red blood ...

A vaso-occlusive crisis (VOC), a hallmark of sickle cell disease (SCD), is an episode of intense pain related to blood vessel blockage and a lack of oxygen supply. In SCD, genetic mutations lead to ...

The causes of sickle cell disease (SCD), an inherited blood disorder, are related to hemoglobin, a protein that helps red blood cells carry oxygen throughout the body. People with sickle cell have ...

When good specialists from a healthcare team move on, it can disrupt a patient's world, writes columnist Mary Shaniqua. But ...

Beam Therapeutics plans to ask the U.S. Food and Drug Administration (FDA) to approve ristoglogene autogetemcel, or risto-cel, its single-dose, gene-edited cell therapy candidate for people with ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google Children with sickle cell anemia, the most common and severe form ...

A sickle cell crisis isn’t a polite guest, and it often arrives unannounced. Over the years, I’ve learned that my crises either come on suddenly or build gradually, with subtle clues or a red alert.

A camp in North Carolina offers children living with sickle cell disease the chance to build confidence, independence, and emotional strength while connecting with others who also live with a chronic ...

Sickle cell disease (SCD) may be cured in some individuals by a stem cell transplant. There also are several approved therapies to help manage the condition and its related complications. Some of the ...

A European Medicines Agency committee has issued a positive opinion on the gene-editing therapy Casgevy (exagamglogene autotemcel) in treating sickle cell disease (SCD) and transfusion-dependent beta ...